The Toronto Prehospital Hypertonic Resuscitation Head Injury and Multi Organ Dysfunction Trial (TOPHR HIT) (TOPHR HIT)
Primary Purpose
Traumatic Brain Injury
Status
Completed
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
hypertonic saline mixed Dextran
Saline solution
Sponsored by
About this trial
This is an interventional treatment trial for Traumatic Brain Injury focused on measuring resuscitation
Eligibility Criteria
Inclusion Criteria:
- Age ≥16
- Initial assessment of Glasgow Coma Score (GCS) 8 or less
- Blunt traumatic mechanism of injury
Exclusion Criteria:
- Known pregnancy
- Penetrating primary injury
- VSA prior to randomization; previous intravenous therapy ≥ 50 ml
- Time interval between arrival at scene and intravenous access exceeds four hours
- Amputation of above wrist or ankle
- Any burn (thermal, chemical, electrical, radiation)
- Suspected hypothermia
- Asphyxia (strangulation, hanging, choking, suffocation, drowning) and fall from height ≤ 1m or ≤ 5 stairs.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
hypertonic saline mixed Dextran
Placebo controlled
Arm Description
hypertonic saline mixed Dextran
Saline solution
Outcomes
Primary Outcome Measures
30 day survival
Secondary Outcome Measures
Survival
•Survival: 48 hours after admission; Hospital discharge
Functional neurological outcomes at 4 months
Neuropsychological testing at 4 months
Neuropsychological testing at 1 year
Physiologic parameters indicative of organ dysfunction
Structural parameters indicative of brain injury or dysfunction at 4 months
Serum inflammatory markers measured on arrival, 12, 24, 48 hours later
Full Information
NCT ID
NCT01642524
First Posted
July 11, 2012
Last Updated
July 13, 2012
Sponsor
Sunnybrook Health Sciences Centre
Collaborators
Defence Research and Development Canada
1. Study Identification
Unique Protocol Identification Number
NCT01642524
Brief Title
The Toronto Prehospital Hypertonic Resuscitation Head Injury and Multi Organ Dysfunction Trial (TOPHR HIT)
Acronym
TOPHR HIT
Official Title
The Toronto Prehospital Hypertonic Resuscitation-Head Injury and Multi Organ Dysfunction Trial
Study Type
Interventional
2. Study Status
Record Verification Date
July 2012
Overall Recruitment Status
Completed
Study Start Date
April 2004 (undefined)
Primary Completion Date
January 2006 (Actual)
Study Completion Date
July 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Sunnybrook Health Sciences Centre
Collaborators
Defence Research and Development Canada
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The TOPHR HIT trial is a clinical trial of patients experiencing blunt trauma who present with an injury to their head which makes them unconscios. The study compares two different fluids given to the patient in the out of hospital setting by a paramedic. The two fluids are salt water (standard treatment) versus a higher concentration of salt water mixed with a sugar (study fluid). The patients have an equal chance of receiving either fluid and the paramedic and the patient and the treating trauma surgeon do not know which fluid was provided in the out of hospital setting.
Detailed Description
Study Objective
The primary objective of this study is to report feasibility in accordance with the methodology described by Lancaster and Dodds, specifically addressing:
baseline survival rates for the treatment and control group to aid in the design of a definitive multicentre trial.
randomization compliance rate.
ease of protocol implementation in the out-of-hospital setting.
adverse rate of Hypertonic Saline Dextran (HSD) infusion.
The secondary objectives include measuring the effect of HSD in modulating the immuno-inflammatory response to severe head injury and its effect on modulating the release of neuro-biomarkers into serum; evaluating the role of serum neuro-biomarkers in predicting patient outcome and clinical response to HSD intervention; evaluating effects of HSD on brain atrophy post-injury and neurocognitive and neuropsychological outcomes.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Traumatic Brain Injury
Keywords
resuscitation
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Single Group Assignment
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
114 (Actual)
8. Arms, Groups, and Interventions
Arm Title
hypertonic saline mixed Dextran
Arm Type
Experimental
Arm Description
hypertonic saline mixed Dextran
Arm Title
Placebo controlled
Arm Type
Placebo Comparator
Arm Description
Saline solution
Intervention Type
Biological
Intervention Name(s)
hypertonic saline mixed Dextran
Intervention Description
single dose administered intravenously
Intervention Type
Biological
Intervention Name(s)
Saline solution
Intervention Description
placebo - saline solution
Primary Outcome Measure Information:
Title
30 day survival
Time Frame
30 days after discharge
Secondary Outcome Measure Information:
Title
Survival
Description
•Survival: 48 hours after admission; Hospital discharge
Time Frame
48 hrs after admission
Title
Functional neurological outcomes at 4 months
Time Frame
4 Months
Title
Neuropsychological testing at 4 months
Time Frame
4 months
Title
Neuropsychological testing at 1 year
Time Frame
1 year
Title
Physiologic parameters indicative of organ dysfunction
Time Frame
4 months
Title
Structural parameters indicative of brain injury or dysfunction at 4 months
Time Frame
4 months
Title
Serum inflammatory markers measured on arrival, 12, 24, 48 hours later
Time Frame
12, 24, 48 hours later
10. Eligibility
Sex
All
Minimum Age & Unit of Time
16 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age ≥16
Initial assessment of Glasgow Coma Score (GCS) 8 or less
Blunt traumatic mechanism of injury
Exclusion Criteria:
Known pregnancy
Penetrating primary injury
VSA prior to randomization; previous intravenous therapy ≥ 50 ml
Time interval between arrival at scene and intravenous access exceeds four hours
Amputation of above wrist or ankle
Any burn (thermal, chemical, electrical, radiation)
Suspected hypothermia
Asphyxia (strangulation, hanging, choking, suffocation, drowning) and fall from height ≤ 1m or ≤ 5 stairs.
12. IPD Sharing Statement
Learn more about this trial
The Toronto Prehospital Hypertonic Resuscitation Head Injury and Multi Organ Dysfunction Trial (TOPHR HIT)
We'll reach out to this number within 24 hrs